CincyTech

Ry Walker, Founder, Astronomer Astronomer is the driving force behind Apache Airflow, the de facto standard for expressing data flows as code Airflow is downloaded more than 4 million times each month and is used by hundreds of thousands of teams around the world

For data teams looking to increase the availability of trusted data, Astronomer provides Astro, the modern data orchestration platform, powered by Airflow Astro enables data engineers, data scientists, and data analysts to build, run, and observe pipelines-as-code Founded in 2018, Astronomer is a global remote-first company with hubs in Cincinnati, New York, San Francisco, and San Jose Customers in more than 35 countries trust Astronomer as their partner for data orchestration

Jan Rosenbaum, Kurome Therapeutics The team at Kurome Therapeutics is operating with a sense of urgency, said Jan Rosenbaum, Ph D , the company’s chief executive officer That’s because therapy initially being developed by Kurome seeks to treat patients with acute myeloid leukemia (AML), a rare and deadly bone marrow cancer that primarily targets adults 50 and older “This disease takes 50% of patients every year,” Rosenbaum said Rosenbaum spent nearly 23 years as a scientist for Procter & Gamble before becoming Kurome’s CEO in April 2020 Kurome is a pre-clinical-stage company developing novel therapies that target cancer cells’ adaptive resistance mechanisms beginning blood cancers Kurome secured the license to develop the therapies from Cincinnati Children’s Medical Center CincyTech led Kurome’s seed-investment round

Peeyush Shrivastava, CEO, Genetesis More than 8 million people go to the emergency room for chest pains every year But 3 out 4 of the cases do not involve heart-related issues Founded in 2017, Genetesis markets the  CardioFlux® medical imaging device to hospital emergency rooms that shows heart activity in a non-invasive manner The imaging process takes 90 seconds and has the potential to provide more effective diagnosis of life-threatening conditions CincyTech and Mark Cuban of Radical Investments led Genetesis' $7 5 million Series A round of financing, and CincyTech led the seed round of funding

CardioFlux®, has been granted Breakthrough Device Designation by the U S Food and Drug Administration (FDA) for the diagnosis of myocardial ischemia and infarction in patients with symptoms of acute chest pain

CincyTech is a public-private seed-stage investor whose mission is to be a hands-on trusted partner in transforming your business or business idea into a high-potential technology or life sciences company We provide core entrepreneurial support services and investment to smart founders and companies throughout Southwest Ohio

One of the most active seed funds in the Midwest, CincyTech is supported by Ohio Third Frontier and more than two dozen foundations, corporations, municipalities and individuals We are also supported by our founding partners: Cincinnati Children’s Hospital Medical Center, the University of Cincinnati, and the Cincinnati USA Regional Chamber

WE BELIEVE IN CHAMPIONING THE BEST IDEAS UNTIL THEY WIN.